Themis Medicare commences supply of Diclofenac Topical Gel to Novartis

16 Jan 2014 Evaluate

Themis Medicare has commenced supply of Diclofenac Topical Gel using TPM Transdermal Drug Delivery System in finished dosage pharmaceutical form to Novartis India (Novartis) as per agreement entered with them on March 26, 2013. The board of directors at its meeting held on January 15, 2014 has taken the note of it.

Themis Medicare is also engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×